BLUESKY ADVISORY GROUP · OTC PATHWAY
01 / 14
Founder Advisory · Confidential

Build Nasdaq
Readiness Before
Nasdaq Scrutiny.

The OTCID → OTCQB → Nasdaq pathway: a staged route from private company to a credible, exchange-ready issuer.

STEP 00
Private
Founder / pre-public
STEP 01
OTCID
Public profile · low friction
STEP 02
OTCQB
Credibility checkpoint
STEP 03
Nasdaq
Uplist from strength

Prepared For

Founder & Principal

Engagement Scope

Structuring · Audit · Counsel · TA · Market Maker · Uplist

Bluesky Advisory Group Limited 2026 · OTC to Nasdaq Pathway
02 · EXECUTIVE THESIS
02 / 14

Nasdaq is the destination.

OTC is the preparation layer.

Direct Nasdaq listing is under heightened practical scrutiny. The OTC bridge creates the public-company operating history that makes the eventual uplist defensible.

  • 01 Direct Nasdaq execution risk is rising across float, audit, governance, and substance review.
  • 02 OTCID provides a staged, lower-friction public-company entry.
  • 03 Substance injection converts a thin profile into a credible operating issuer.
  • 04 OTCQB becomes the credibility checkpoint before the Nasdaq application.
  • 05 Advisory engagement coordinates the critical path — sequencing, not just filing.
Thesis 02 / 14
03 · THE FOUNDER'S PROBLEM
03 / 14
01.

The gap is not ambition.

It is readiness.

Nasdaq listing requires more than meeting numeric thresholds.

  • · Audit & PCAOB-quality financial reporting
  • · Governance & board / controls maturity
  • · Public float & shareholder base credibility
  • · Disclosure discipline & cap-table hygiene
  • · Market infrastructure: TA, DTC, market maker
  • · Investor narrative the market can price

A direct attempt without preparation creates delay and credibility risk.

Act I 03 / 14
04 · THE NEW SCRUTINY LANDSCAPE
04 / 14

Heightened SEC and Nasdaq scrutiny have changed the calculus for direct listings.

Six friction points where the practical bar is higher today. Framed as heightened execution scrutiny, not a formal Nasdaq ban on direct routes.

Friction Point Current Reality Impact on Issuers
AOperating Substance
Nasdaq 5210 / IM-5210 Qualitative business review Beyond financial thresholds
Adds 30–60 days; thin operations get deferred or denied.
+30–60D
BPublic Float & Liquidity
Nasdaq 5405 $15M public float 5810 continued-listing
Float must be planned, not engineered at the wire.
FLOAT-LED
CGovernance Readiness
Nasdaq 5605 Indep. directors Audit / comp committees
Board must be built before filing; no post-listing grace.
PRE-FILING
DPCAOB Audit Quality
PCAOB-registered HFCAA framework Inspection deficiencies
Auditor selection is a gating item; boutique firms risk delays.
GATING
EInvestor Protection
Nasdaq 5210 RTO history Related-party density
Shell-legacy issuers carry an evidence burden on operating status.
EVIDENCE
FDisclosure Completeness
S-1 / F-1 Item 601 Reg S-K segments
Plan for iterative comment cycles, not a single-pass filing.
ITERATIVE
Pre-2024 · Mechanical
Threshold-driven: meet the financial tests, file compliant disclosure, get approved on a predictable timeline.
2026 · Discretionary
Qualitative: the same issuer cleared in 2022 may be deferred in 2026 for substance, governance, or disclosure depth.

Implication: the route remains open for issuers with scale, governance, and operating history. Cite: Nasdaq 5210 / 5405 / 5505 / 5605 / 5810 · Reg S-K · HFCAA.

Execution Risk 04 / 14
05 · THE OTC BRIDGE
05 / 14

A staged route to become a better Nasdaq candidate.

The path: establish OTCID public profile, inject operating substance, upgrade to OTCQB, build reporting and market track record, and apply for the Nasdaq uplist from a stronger base.

1.
Establish OTCID
Public profile under OTCID tier.
~9–12 months
2.
Inject Substance
Operating business combination.
Within OTCID phase
3.
OTCQB Upgrade
Higher-quality marketplace.
~1–2 months
4.
Nasdaq Uplist
Apply from credible base.
~6–12 months

Timeline bands are illustrative; project-specific dates set after diagnostic.

Strategy 05 / 14
06 · WHY THIS ROUTE
06 / 14

OTCID first.

Credibility second.

Nasdaq third.

The OTC Bridge is recommended over a direct listing because the staged architecture is itself the value driver — it produces the readiness that Nasdaq rewards.

  • · Lower initial friction than direct Nasdaq application
  • · Earlier public-company familiarity for the team
  • · Time to build audit, governance, disclosure, and TA infrastructure
  • · Better control of Nasdaq timing — you choose the window
  • · Phased advisory scope instead of all-or-nothing engagement
  • · Lower execution shock at the eventual uplist
Recommended Path 06 / 14
07 · PATH COMPARISON
07 / 14

Three routes. One destination.

Compared on the dimensions that matter for a founder evaluating a pathway today. Recommended row is highlighted.

Dimension Direct Nasdaq OTC Bridge RTO Shell Shortcut
Speed to public status High Medium Highest
Regulatory scrutiny timing Front-loaded Staged Delayed / spiky
Cost control Tight, big upfront Phased Unpredictable
Credibility at destination Strong Strong Impaired
Nasdaq readiness Built in parallel Built in stages Backfilled
Shell / liability risk Low Low High
Founder control Tight window Phased Diluted

Verdict: OTC Bridge wins on staged readiness; direct Nasdaq wins on speed; RTO wins on paper but loses on credibility.

Comparison 07 / 14
08 · EXECUTION ROADMAP
08 / 14

Four stages from OTCID to Nasdaq readiness.

Stages are sequential, not parallel. Each one produces a deliverable that unlocks the next.

01
Structuring & OTCID
Corporate restructure, TA, market maker, OTCID application, profile and disclosure setup.
Deliverable · OTCID public profile
02
Substance Injection
Operating business combination, audited financials, pro formas, cap-table cleanup, governance appointments.
Deliverable · Operating issuer status
03
OTCQB Upgrade
Eligibility, certification, verified profile, TA verification, ongoing disclosure discipline.
Deliverable · OTCQB listing
04
Nasdaq-Readiness Buildout
Eligibility mapping, board build-out, IR narrative, prospectus-grade disclosure, application package.
Deliverable · Nasdaq application
Sequencing matters — each gate is a check on the next. Critical path
Roadmap 08 / 14
09 · WORKSTREAM CONTROL MAP
09 / 14

Ten workstreams. One owner per cell.

Coordinating counterparties is the engagement. Without it, the work drifts and the critical path breaks.

W-01
Corporate Structuring
W-02
U.S. Securities Counsel
W-03
PCAOB Audit / Reporting
W-04
Transfer Agent
W-05
Market Maker / Form 211
W-06
OTC Markets Application
W-07
DTC Eligibility
W-08
Governance & Board
W-09
IR & Market Narrative
W-10
Nasdaq Eligibility
Engagement = sequencing + counterparties + deliverables. 10 Workstreams
Coordination 09 / 14
10 · SUBSTANCE INJECTION
10 / 14

The inflection point from public profile to credible operating issuer.

Two halves: deal mechanics and disclosure mechanics. Both must be sequenced to the audit opinion date.

Deal Mechanics

Operating business acquisition / share exchange / contributionSHELL → OP
Audited target financials (2-yr + interim)PCAOB
Pro forma combined financials & disclosuresART. 11
Cap table cleanup · cancellation of legacy shell equityPRE-8-K
Related-party agreements & disclosureItem 404
Valuation support for shares / assets contributedFAIR VALUE

Disclosure Mechanics

Super 8-K (Item 2.01 + Item 5.01) within 4 business daysFORM 8-K
Form 10-level information if shell status requiresINFO STMT
Risk factors, MD&A, segment disclosure for new businessREG S-K
Governance appointments · independent directors · committeesBOARD
D&O coverage, insider trading policy, code of ethicsCONTROLS
Investor narrative & IR readiness materialsSTORY

Verify exact filing requirements against issuer status and transaction structure before execution.

Substance 10 / 14
11 · OTCQB UPGRADE
11 / 14

OTCQB is the credibility checkpoint before Nasdaq.

The marketplace requirements are real but achievable. Six focus areas, each tied to a specific deliverable.

Verify current OTCQB standards and 2025+ reform details with OTC Markets primary sources.

01

Market Standards

Minimum bid price threshold, share structure, and freely-tradable share count.

02

Annual Certification

Current information, annual certification, fees, and disclosure review on schedule.

03

Verified Profile

OTC Markets verified profile with operating-company metadata, officers, and address verification.

04

Transfer Agent

TA verification of share count, shareholder record, and DTC participation status.

05

Disclosure Discipline

Ongoing reporting cadence, news dissemination, and 15c2-11 compliance posture.

06

Investor Credibility

Market-maker depth, spread, and retail/institutional visibility on the OTCQB tier.

Credibility 11 / 14
12 · READINESS SCORECARD
12 / 14

Nasdaq Readiness Scorecard.

Score yourself on each dimension. Default weights mirror our pre-engagement diagnostic.

0–5
0–5
0–5
0–5
0–5
0–5
0–5
0–5
Readiness Score
—
Out of 100
Awaiting input
Interactive · Scorecard 12 / 14
13 · COST / TIMELINE SCENARIO
13 / 14

Choose the pace. See the trade-off.

Qualitative bands only — project-specific facts drive real numbers. Use this to pressure-test the critical path.

Partial
Medium
Medium
Medium
Base
Phase-by-Phase Estimate
OTCID build
Public profile + substance
9–12 mo
OTCID → OTCQB
Upgrade + certification
1–2 mo
OTCQB → Nasdaq
Uplist from strength
6–12 mo
Total · OTCID → Nasdaq-track 16–26 mo
Medium intensity
Interactive · Scenario 13 / 14
14 · THE ASK
14 / 14

The next 30 days.

Five decisions in five weeks. None of them are irreversible — together they unblock everything downstream.

Day 1

Approve mandate

Sign advisory engagement letter with the 5-stage scope.

Day 7

Begin diagnostic

Walk the readiness scorecard, identify top three gaps.

Day 14

Map structure & cap table

Corporate structure audit, shareholder register, related-party review.

Day 21

Appoint counterparties

U.S. securities counsel, PCAOB auditor, transfer agent, market maker.

Day 30

Execution calendar + blockers

OTCID → OTCQB → Nasdaq calendar; first 10 blocking items.

Bluesky.
Advisory Group Limited
Founder Advisory · Cross-border listings
Decision ask 14 / 14